Replies to post #199009 on Biotech Values

[DewDiligence]

ABBV/Roche—FDA approves Venclexta (venetoclax) for second-line CLL with 17p deltion:

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm495253.htm

The approval came three months before the (7/11/16) PDUFA date.